# Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease

> **NCT01861288** · — · COMPLETED · sponsor: **Herlev Hospital** · enrollment: 157 (actual)

## Conditions studied

- Inflammatory Bowel Disease
- Crohn Disease
- Ulcerative Colitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01861288
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-01
- **Primary completion:** 2016-09-05
- **Final completion:** 2018-02-28
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2019-02-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01861288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01861288, "Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01861288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*